BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 25303160)

  • 1. A patient with medulloblastoma in its early developmental stage.
    Shinojima N; Nakamura H; Tasaki M; Kameno K; Anai S; Iyama K; Ando Y; Seto H; Kuratsu J
    J Neurosurg Pediatr; 2014 Dec; 14(6):615-20. PubMed ID: 25303160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medulloblastoma comprises four distinct molecular variants.
    Northcott PA; Korshunov A; Witt H; Hielscher T; Eberhart CG; Mack S; Bouffet E; Clifford SC; Hawkins CE; French P; Rutka JT; Pfister S; Taylor MD
    J Clin Oncol; 2011 Apr; 29(11):1408-14. PubMed ID: 20823417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temporal evolution of medulloblastoma subgroups.
    Manoranjan B; Singh SK
    J Neurosurg Pediatr; 2015 Sep; 16(3):349-50. PubMed ID: 26023848
    [No Abstract]   [Full Text] [Related]  

  • 4. Response.
    Shinojima N; Nakamura H; Kuratsu J
    J Neurosurg Pediatr; 2015 Sep; 16(3):350-1. PubMed ID: 26554079
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical implications of medulloblastoma subgroups: incidence of CSF diversion surgery.
    Schneider C; Ramaswamy V; Kulkarni AV; Rutka JT; Remke M; Tabori U; Hawkins C; Bouffet E; Taylor MD
    J Neurosurg Pediatr; 2015 Mar; 15(3):236-42. PubMed ID: 25525930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medulloblastoma with extensive nodularity (SHH medulloblastoma).
    Fudyma IA; Wadhwani NR
    Pol J Pathol; 2017; 68(4):364-366. PubMed ID: 29517209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Approach to molecular subgrouping of medulloblastomas: Comparison of NanoString nCounter assay versus combination of immunohistochemistry and fluorescence in-situ hybridization in resource constrained centres.
    Kaur K; Jha P; Pathak P; Suri V; Sharma MC; Garg A; Suri A; Sarkar C
    J Neurooncol; 2019 Jul; 143(3):393-403. PubMed ID: 31104222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Large cell/anaplastic medulloblastomas and medullomyoblastomas: clinicopathological and genetic features.
    Leonard JR; Cai DX; Rivet DJ; Kaufman BA; Park TS; Levy BK; Perry A
    J Neurosurg; 2001 Jul; 95(1):82-8. PubMed ID: 11453402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calbindin-D28k in subsets of medulloblastomas and in the human medulloblastoma cell line D283 Med.
    Katsetos CD; Herman MM; Krishna L; Vender JR; Vinores SA; Agamanolis DP; Schiffer D; Burger PC; Urich H
    Arch Pathol Lab Med; 1995 Aug; 119(8):734-43. PubMed ID: 7646332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in vascular endothelial growth factor receptor expression and correlation with the degree of enhancement in medulloblastoma.
    Hervey-Jumper SL; Garton HJ; Lau D; Altshuler D; Quint DJ; Robertson PL; Muraszko KM; Maher CO
    J Neurosurg Pediatr; 2014 Aug; 14(2):121-8. PubMed ID: 24905841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Embryonal brain tumor with unknown primary lesion and massive cerebrospinal fluid dissemination: A case report.
    Tanaka H; Yamamoto D; Ikeda M; Morikawa M; Ueda K; Tanaka K; Sasayama T; Kohmura E
    J Clin Neurosci; 2018 Aug; 54():125-128. PubMed ID: 29843922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Examination of somatostatin receptor expression in recurrent childhood medulloblastomas].
    Kaszper E; Hanzély Z; Szende B; Dabasi G; Garami M; Schuler D; Hauser P
    Magy Onkol; 2008 Dec; 52(4):351-5. PubMed ID: 19068462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomics identifies medulloblastoma subgroups that are enriched for specific genetic alterations.
    Thompson MC; Fuller C; Hogg TL; Dalton J; Finkelstein D; Lau CC; Chintagumpala M; Adesina A; Ashley DM; Kellie SJ; Taylor MD; Curran T; Gajjar A; Gilbertson RJ
    J Clin Oncol; 2006 Apr; 24(12):1924-31. PubMed ID: 16567768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic Accuracy of a Reduced Immunohistochemical Panel in Medulloblastoma Molecular Subtyping, Correlated to DNA-methylation Analysis.
    Tauziède-Espariat A; Huybrechts S; Indersie E; Dufour C; Puget S; Chivet A; Roux A; Pagès M; Gareton A; Chrétien F; Lechapt E; Ayrault O; Varlet P
    Am J Surg Pathol; 2021 Apr; 45(4):558-566. PubMed ID: 33323893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uniformity under in vitro conditions: Changes in the phenotype of cancer cell lines derived from different medulloblastoma subgroups.
    Chlapek P; Zitterbart K; Kren L; Filipova L; Sterba J; Veselska R
    PLoS One; 2017; 12(2):e0172552. PubMed ID: 28231263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytogenetic prognostication within medulloblastoma subgroups.
    Shih DJ; Northcott PA; Remke M; Korshunov A; Ramaswamy V; Kool M; Luu B; Yao Y; Wang X; Dubuc AM; Garzia L; Peacock J; Mack SC; Wu X; Rolider A; Morrissy AS; Cavalli FM; Jones DT; Zitterbart K; Faria CC; Schüller U; Kren L; Kumabe T; Tominaga T; Shin Ra Y; Garami M; Hauser P; Chan JA; Robinson S; Bognár L; Klekner A; Saad AG; Liau LM; Albrecht S; Fontebasso A; Cinalli G; De Antonellis P; Zollo M; Cooper MK; Thompson RC; Bailey S; Lindsey JC; Di Rocco C; Massimi L; Michiels EM; Scherer SW; Phillips JJ; Gupta N; Fan X; Muraszko KM; Vibhakar R; Eberhart CG; Fouladi M; Lach B; Jung S; Wechsler-Reya RJ; Fèvre-Montange M; Jouvet A; Jabado N; Pollack IF; Weiss WA; Lee JY; Cho BK; Kim SK; Wang KC; Leonard JR; Rubin JB; de Torres C; Lavarino C; Mora J; Cho YJ; Tabori U; Olson JM; Gajjar A; Packer RJ; Rutkowski S; Pomeroy SL; French PJ; Kloosterhof NK; Kros JM; Van Meir EG; Clifford SC; Bourdeaut F; Delattre O; Doz FF; Hawkins CE; Malkin D; Grajkowska WA; Perek-Polnik M; Bouffet E; Rutka JT; Pfister SM; Taylor MD
    J Clin Oncol; 2014 Mar; 32(9):886-96. PubMed ID: 24493713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medulloblastoma with multi-lineage differentiation including myogenic and melanotic elements: a case report with molecular data.
    Stefanits H; Ebetsberger-Dachs G; Weis S; Haberler C
    Clin Neuropathol; 2014; 33(2):122-7. PubMed ID: 24131750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predisposition of Wingless Subgroup Medulloblastoma for Primary Tumor Hemorrhage.
    Reisinger D; Gojo J; Kasprian G; Haberler C; Peyrl A; Azizi AA; Mayr L; Chocholous M; Kool M; Czech T; Slavc I
    Neurosurgery; 2020 Apr; 86(4):478-484. PubMed ID: 31065705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epithelial differentiation in medulloblastoma: comparison with other embryonal tumors of neuroectodermal origin.
    Sugita Y; Tokunaga O; Terasaki M; Morimatsu M; Shigemori M
    Pathol Int; 2003 Dec; 53(12):858-64. PubMed ID: 14629752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular subgroups of medulloblastoma identification using noninvasive magnetic resonance spectroscopy.
    Blüml S; Margol AS; Sposto R; Kennedy RJ; Robison NJ; Vali M; Hung LT; Muthugounder S; Finlay JL; Erdreich-Epstein A; Gilles FH; Judkins AR; Krieger MD; Dhall G; Nelson MD; Asgharzadeh S
    Neuro Oncol; 2016 Jan; 18(1):126-31. PubMed ID: 26254476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.